Adiponectin and Osteocalcin: Relation to Insulin Sensitivity
Overview
Cell Biology
Affiliations
Obesity and osteoporosis have grave consequences for human health, quality of life, and even the efficiency of the labor force. Interestingly, these diseases share several features including a genetic predisposition and a common progenitor cell. Recent findings show that high adipocyte count in bone marrow is directly related to bone loss, as fat cells replace osteoblasts resulting in reduced bone mineral density and increased propensity towards osteoporosis. This close relationship has a positive aspect, whereby higher osteocalcin levels results in increased adiponectin production while the presence of adiponectin influences osteoblast proliferation and differentiation in a positive way. We focus on how osteoblasts and adipocytes affect each other and ultimately insulin resistance through the hormones they produce. This approach to whole animal physiology is the main stay of Alternative Medicine. It is assumed that the body is linked together intricately, and treating one is equal to treating the whole body. As we go further into bone and adipocytes physiology, it is evident that these organs affect each other. Therefore, elucidation on the actions of fat on bone and vice versa will unravel the complex mechanism of insulin resistance.
Osteocalcin and Its Potential Functions for Preventing Fatty Liver Hemorrhagic Syndrome in Poultry.
Tu W, Zhang Y, Jiang K, Jiang S Animals (Basel). 2023; 13(8).
PMID: 37106943 PMC: 10135196. DOI: 10.3390/ani13081380.
Hassler E, Almer G, Reishofer G, Deutschmann H, Renner W, Herrmann M Nutrients. 2022; 14(1).
PMID: 35010988 PMC: 8747071. DOI: 10.3390/nu14010112.
Leptin to adiponectin ratio in puberty is associated with bone mineral density in 18-year-old males.
Tamme R, Jurimae J, Maestu E, Remmel L, Purge P, Mengel E Bone Rep. 2022; 16:101158.
PMID: 34977280 PMC: 8683673. DOI: 10.1016/j.bonr.2021.101158.
Stojanovic S, Arsenijevic N, Djukic A, Djukic S, Zivancevic Simonovic S, Jovanovic M Acta Endocrinol (Buchar). 2019; 14(2):201-207.
PMID: 31149258 PMC: 6516524. DOI: 10.4183/aeb.2018.201.
Lombardi G, Ziemann E, Banfi G Front Endocrinol (Lausanne). 2019; 10:60.
PMID: 30792697 PMC: 6374307. DOI: 10.3389/fendo.2019.00060.